NCT06409052 Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
| NCT ID | NCT06409052 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Endometrial Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 45 participants |
| Start Date | 2024-06-25 |
| Primary Completion | 2026-08-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 45 participants in total. It began in 2024-06-25 with a primary completion date of 2026-08-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To learn more about women's attitudes toward and knowledge about endometrial cancer and options that might decrease the risk of developing
Eligibility Criteria
Inclusion Criteria: 1. Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of endometrial cancer 2. Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of abnormal uterine bleeding or endometrial hyperplasia 3. Women without a diagnosis of endometrial cancer or endometrial hyperplasia 4. Women must be at least 18 years or age 5. Women must be able to read, write, and speak English 6. Women must be willing and able to provide written informed consent Exclusion Criteria:
Contact & Investigator
Larissa Meyer, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06409052 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Endometrial Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06409052 currently recruiting?
Yes, NCT06409052 is actively recruiting participants. Contact the research team at lmeyer@mdanderson.org for enrollment information.
Where is the NCT06409052 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06409052 clinical trial?
NCT06409052 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Larissa Meyer, MD at M.D. Anderson Cancer Center. The trial plans to enroll 45 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.